Lärkberget AB (publ) (STO:COMBI)
Sweden · Delayed Price · Currency is SEK 2.470
-0.100 (-3.89%)
Jun 25, 2025, 3:18 PM CET
Lärkberget AB Company Description
CombiGene AB (publ) operates as an investment company.
It is involved in Direct investments in low-risk instruments; Financial investments; Direct investments in unlisted profitable companies; and Reverse acquisition platform.
The company was formerly known as CombiGene AB (publ) and changed its name to Lärkberget AB (publ) in June 2025.
Lärkberget AB (publ) was incorporated in 1990 and is based in Östermalm, Sweden.
Lärkberget AB (publ)
| Country | Sweden |
| Founded | 1990 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Peter Ekolind |
Contact Details
Address: Aboutvalue Östermalm, 114 34 Sweden | |
| Phone | 46 7 35 30 37 98 |
| Website | larkberget.se |
Stock Details
| Ticker Symbol | COMBI |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0016101935 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Peter Ekolind | Chief Executive Officer |
| Annika Ericson | Chief Scientific Officer |